REGISTRY PRIVACY · EFFECTIVE NOVEMBER 2026
Study Registry Privacy Notice
Jump to section
1. Purpose and Scope of the Study Registry
GeneSI Labs, Inc. (“GeneSI”, “we”, “us”, or “our”) maintains a Study Registry for individuals, researchers, and institutional partners who express interest in participating in genomic research studies, sequencing validation cohorts, or technology evaluations conducted by GeneSI and our collaborating academic research centers.
This Study Registry Privacy Notice explains how we collect, store, de-identify, use, and protect information submitted when you register your interest in our ongoing and future research studies. Registering your interest does not obligate you to participate in any study program, nor does it guarantee enrollment in any specific protocol.
2. Information We Collect Through the Registry
When you complete a registration of interest for our study registry, we collect information across three main categories:
- Contact and Identification Details: Name, institutional or personal email address, telephone number, geographic region or state of residence, and preferred communication method.
- Research and Target Interest Areas: General areas of genomic interest (such as specific hereditary conditions, targeted sequence regions, or genetic variant families under investigation).
- Institutional and Laboratory Profile: For laboratory professionals, investigators, or genetic specialists registering on behalf of research cohorts: institutional affiliation, facility type, and sequencing platform specifications.
3. Genomic Sequence Data and Specimen Handling
The web-based Study Registry intake form collects contact and background interest information only. It does not collect or receive biological specimens, blood samples, or raw genomic sequence files.
Any subsequent participation in a specific research protocol that involves biological sample contribution or genomic sequencing is conducted strictly under a separate, formal Informed Consent process governed by an authorized Institutional Review Board (IRB) or independent ethics committee.
4. How We Use Registry Information
We use the information gathered through the Study Registry exclusively for legitimate scientific, observational, and registry administration purposes, including:
- Assessing eligibility and alignment with active or upcoming genomic research protocols.
- Contacting registered participants with informational updates about new study opportunities, protocol openings, or published research findings.
- Prioritizing target genomic regions and primer designs for the GENESI-X1 library based on aggregated research demand.
- Maintaining an accurate, secure registry of volunteer participants and collaborative institutional contacts.
5. De-Identification and Participant Confidentiality
We apply rigorous confidentiality protections to all registry records. Identifying information (such as your name and contact details) is stored in an access-controlled, encrypted registry repository that is physically and logically separated from computational sequence analysis environments.
When registry metrics are reviewed for cohort planning or feasibility analyses, data is de-identified and assigned a pseudo-anonymous unique Study Identification Code. Only designated registry coordinators are authorized to link a Study Identification Code back to direct contact details for official study correspondence.
6. Voluntary Participation and Informed Consent
Participation in the GeneSI Study Registry is entirely voluntary. You may choose not to register, or you may choose to answer only the questions you feel comfortable sharing.
If your profile matches the eligibility parameters of a specific genomic research study, a study coordinator may contact you with detailed information. You will always have the freedom to accept or decline participation in any offered study protocol without any adverse consequences.
7. Information Sharing and Disclosures
GeneSI does not sell, rent, or trade registry information to third parties, commercial brokers, or advertising networks. We share registry data strictly under the following controlled circumstances:
- Authorized Institutional Investigators: Collaborating principal investigators and academic researchers who have executed binding confidentiality and data security agreements with GeneSI.
- Secure Technology Providers: Cloud infrastructure and database hosting vendors operating under strict security and confidentiality commitments.
- Legal and Regulatory Authorities: When required by applicable statutory mandates, research compliance directives, or formal legal processes.
8. Security and Data Protection Safeguards
GeneSI implements industry-leading administrative, technical, and physical safeguards to protect registry data against loss, misuse, unauthorized access, or unauthorized disclosure.
All registry submissions are encrypted in transit using Transport Layer Security (TLS 1.3) and encrypted at rest using AES-256 standards. Multi-factor authentication, principle-of-least-privilege access permissions, and automated audit logging are enforced across all registry databases.
9. Data Retention and Your Right to Withdraw
We retain your registry profile for as long as your registration remains active, or until you decide to withdraw. You maintain the right to withdraw from the Study Registry at any time for any reason.
To request withdrawal or update your contact information, submit a request to registry@genesilabs.xyz. Upon receiving your withdrawal request, your contact information will be permanently removed from active registry databases.
10. Contact Us
If you have questions, concerns, or requests regarding this Study Registry Privacy Notice or our participant data safeguards, please contact our team:
- Study Registry Coordinator: registry@genesilabs.xyz
- Data Protection Officer: privacy@genesilabs.xyz
Looking for another document? Visit our Privacy Policy, Terms of Use, or Study Registry Privacy Notice.